Matthew Scott Harris

Insider Reports History

Entity
Individual
Location
C/O Altimmune, Inc., 910 Clopper Road, Suite 201 S, Gaithersburg, MD
Signature
/s/ Andrew Shutterly as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Scott Harris:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Altimmune, Inc. Chief Medical Officer Common Stock, par value $0.0001 55.1K $298K $5.41 Jul 31, 2024 Direct
Altimmune, Inc. Chief Medical Officer Stock Options (option to buy) 163K Jan 25, 2024 Direct
Altimmune, Inc. Chief Medical Officer Restricted Stock Units 15.6K Feb 2, 2024 Direct

Insider Reports Filed by Matthew Scott Harris

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALT Altimmune, Inc. Jul 31, 2024 1 $8.04K 4 Aug 1, 2024 Chief Medical Officer
ALT Altimmune, Inc. Feb 1, 2024 6 -$39.5K 4 Feb 5, 2024 Chief Medical Officer
ALT Altimmune, Inc. Jan 30, 2024 4 -$17.8K 4 Feb 1, 2024 Chief Medical Officer
ALT Altimmune, Inc. Jan 25, 2024 2 $0 4 Jan 29, 2024 Chief Medical Officer
ALT Altimmune, Inc. Jul 31, 2023 1 $1.94K 4 Aug 2, 2023 Chief Medical Officer
ALT Altimmune, Inc. Mar 23, 2023 1 $42.2K 4 Mar 23, 2023 Chief Medical Officer
ALT Altimmune, Inc. Feb 2, 2023 3 -$35.6K 4 Feb 6, 2023 Chief Medical Officer
ALT Altimmune, Inc. Jan 31, 2023 4 -$16.9K 4 Feb 2, 2023 Chief Medical Officer
ALT Altimmune, Inc. Jan 30, 2023 2 $0 4 Feb 1, 2023 Chief Medical Officer
ALT Altimmune, Inc. Jul 31, 2022 1 $7.38K 4 Aug 3, 2022 Chief Medical Officer
ALT Altimmune, Inc. Feb 28, 2022 3 -$168K 4 Mar 2, 2022 Chief Medical Officer
ALT Altimmune, Inc. Jan 31, 2022 6 -$5.07K 4 Feb 3, 2022 Chief Medical Officer
ALT Altimmune, Inc. Jul 31, 2021 1 $5.59K 4 Aug 6, 2021 Chief Medical Officer